All Posts
Resources

New Data Published on High DHA and Testosterone in Overweight Men

Published on
November 26, 2020
Contributors
Derek Tobin, PhD
Business Development and Clinical Science Manager

At Epax, we believe the best approach to great scientific insights is a combination of independent and own studies. In fact, there are more than 100 peer-reviewed clinical studies using Epax products! Recently, new, independent data were published on high-DHA Epax oil and testosterone levels in overweight and obese men. Access the publication here, or read the NutraIngredients USA article coverage here.

Articles

Discover More

Continue exploring the latest stories, research, and breakthroughs from the world of Epax®.

Resources
5 min read

The Omega dream team: EPAX Omega 3-9-11

Discover the science behind EPAX® Omega 3-9-11, a breakthrough marine oil combining Omegas 3, 9, and 11 for advanced health benefits. Developed using Epax’s pioneering distillation technology, this unique blend harnesses the power of North Atlantic fish to deliver high-purity LC-PUFA and LC-MUFA. Backed by research, EPAX® Omega 3-9-11 supports heart, skin, and metabolic health, offering a new frontier in marine lipid nutrition.
Read more
Resources
5 min read

Beyond Omega-3: EPAX Evolve 05

EPAX® Evolve 05 is a concentrated marine Omega-3 formula containing lipids that go beyond long-chain EPA and DHA. Epax has developed technology to produce a concentrated oil abundant in very long chain polyunsaturated fatty acids (VLC-PUFA),which play essential roles in various physiological functions within the body. Here, we elaborate on the significance of these fatty acids in relation to longevity, tears, vision and male fertility.
Read more
Resources
5 min read

Study indicates benefits of EPAX 4020 TGN for muscle function and recovery

EPAX 4020 TGN has been shown in a pre-clinical study to help improve post-injury muscle recovery and maintain neuromuscular performance in aging, a pilot study has found.
Read more
Resources
5 min read

Epax research paper nominated for BJN Paper of the Year 2024

Epax has achieved a significant milestone with their scientific paper on VLC-fatty acids being nominated by the British Journal of Nutrition for the BJN Paper of the Year 2024.
Read more